School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.
Acta Ophthalmol. 2024 May;102(3):e229-e244. doi: 10.1111/aos.15746. Epub 2023 Aug 14.
To compare the treatment efficacy of childhood myopia control optical interventions [spectacles, soft contact lenses (SCLs) and orthokeratology (OK) lenses], explore the consistency of treatment efficacies during the treatment period and evaluate the impact of baseline spherical equivalent refraction (SER), axial length (AL) and age on the treatment effect. A literature search of EMBASE, PubMed and Google Scholar databases identified 220 articles published between January 2000 and April 2022, which reported the treatment efficacy by differences in the SER and AL change between intervention and control groups. Thirty-five articles were included in the analysis. Treatment effect sizes (ESs) were calculated, where more positive and negative directions indicated greater treatment efficacy for SER and AL respectively. For SER, the ESs with peripheral add design spectacles (0.66) and SCLs (0.53) were large but not significantly different between treatment types (p = 0.69). For AL, ESs with peripheral add design spectacles (-0.37), SCLs (-0.55) and OK lenses (-0.93) were large, but OK lenses had a significantly greater effect than peripheral add design spectacles (p ≤ 0.001). ESs were large during the first 12 months of treatment for all interventions [peripheral add design SCLs and OK (F ≥ 5.39, p ≤ 0.01), peripheral add design spectacles (F = 0.47, p = 0.63)] but reduced towards the end of 24-36 months of treatment. Baseline SER had an impact on the treatment effect with peripheral add design spectacles only. Optical interventions are efficacious in controlling childhood myopia progression. However, treatment effects were largest only during the first 12 months of treatment and reduced over time.
为了比较儿童近视控制光学干预措施(眼镜、软性隐形眼镜(SCL)和角膜塑形术(OK)镜片)的治疗效果,探索治疗期间治疗效果的一致性,并评估基础球镜等效屈光度(SER)、眼轴(AL)和年龄对治疗效果的影响。通过对 EMBASE、PubMed 和 Google Scholar 数据库的文献检索,共检索到 2000 年 1 月至 2022 年 4 月期间发表的 220 篇报告干预组和对照组之间 SER 和 AL 变化差异的治疗效果的文章。其中 35 篇文章被纳入分析。计算了治疗效果大小(ES),其中更正向和负向的方向分别表示 SER 和 AL 的治疗效果更大。对于 SER,周边附加设计眼镜(0.66)和 SCL(0.53)的 ES 较大,但治疗类型之间无显著差异(p=0.69)。对于 AL,周边附加设计眼镜(-0.37)、SCL(-0.55)和 OK 镜片(-0.93)的 ES 较大,但 OK 镜片的效果明显大于周边附加设计眼镜(p≤0.001)。所有干预措施在前 12 个月治疗期间的 ES 较大[周边附加设计 SCL 和 OK(F≥5.39,p≤0.01),周边附加设计眼镜(F=0.47,p=0.63)],但在 24-36 个月治疗结束时降低。只有周边附加设计眼镜的基础 SER 对治疗效果有影响。光学干预措施在控制儿童近视进展方面是有效的。然而,治疗效果仅在治疗的前 12 个月最大,随着时间的推移而降低。